NEW YORK--()--Guard Dog Brand Development (www.GuardDogBD.com) is proud to be an event exhibitor and sponsor of CBI’s 4th Annual Forum on Oncology Commercialization Strategies on Thursday, January 20, 2011 at the Courtyard Philadelphia Downtown, Philadelphia, PA.
“Oncology is one of the most highly competitive and complex therapeutic areas and the makings of a successful launch starts years before a product ever hits the market”
“Oncology is one of the most highly competitive and complex therapeutic areas and the makings of a successful launch starts years before a product ever hits the market,” said Maria Casini, co-founder of Guard Dog Brand Development, a boutique company with a particular expertise in early science and brand identity development for oncology products.
Camille DeSantis, co-founder of Guard Dog notes: “Given Guard Dog’s expertise in oncology, we believed it critically important to sponsor this event, which will convene a variety of thought leaders in the industry who will explore the key elements of the commercialization side of oncology. With identity representing at least 25% the perceived value of a product, we believe identity development needs to be considered essential to every successful commercialization plan.”
About Guard Dog Brand Development® (GDBD):
GDBD is an independent novel brand development company specializing in creating and fiercely protecting corporate, product, and science identities especially in the life sciences. Please visit www.GuardDogBD.com for more information.
About CBI’s 4th Annual Forum on Oncology Commercialization Strategies
This annual forum examines oncology-specific commercial planning for each stage of the product lifecycle and cutting-edge approaches used by the leading manufacturers of oncology products. For more information, go to www.cbinet.com/Oncology or call 1-800-817-8601.

